San Diego, CA – Mintz is pleased to announce that Member Kenneth E. Jenkins, Ph.D. was named to San Diego Business Journal's 2023 “Leaders of Influence in the Life Sciences” special edition, which recognizes industry leaders in the life sciences and highlights their careers and accomplishments.
The accompanying profile showcases Dr. Jenkins' significant contributions to DTx Pharma, where he began providing counseling to the CEO prior to the company's formation. He has been an integral part of the company's journey, which includes its recent acquisition by Novartis for $500 million with additional potential payments of up to $500 million upon completion of certain milestones. Additionally, Dr. Jenkins role as primary outside patent counsel for the City of Hope, a prestigious National Cancer Institute-designated comprehensive cancer center, is highlighted. In this capacity, he handles their most critical intellectual property across various technologies, particularly focusing on antibody-based cancer therapeutics.
Dr. Jenkins is a highly regarded intellectual property attorney focused on patent prosecution and counseling work for a diverse set of clients, from research institutions to pre-funded startups to some of the world’s largest life sciences companies. He has extensive patent procurement experience in disruptive bioscience and chemical technologies, such as antibody therapeutics, small molecule modulators, diagnostics, immuno-oncotherapies, pharmaceutical formulations, gene editing, siRNA therapeutics, stem cell therapies, nanotechnologies, and machine learning and AI in Life Sciences technologies, among others.
Click here to view Dr. Jenkins full profile and to view the complete list of honorees.
For more information about Mintz, please visit www.mintz.com.